AstraZeneca-linked ovarian cancer trial posts results; myeloma follow-up study status reconfirmedNov 13Weekly roundup, 10 itemsAstraZenecaAZD0120Updated
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Tezspire meets primary endpoints in Phase III EoE trial CROSSINGAug 27Clinical readoutAmgenAstraZeneca
AstraZeneca posts MITCHELL asthma results; registers AZD6234 Phase 3 SELENE 2Aug 27Weekly roundup, 7 itemsAstraZenecaAZD4144
AstraZeneca posts PASSAGE Phase 4 tezepelumab results; registers new prostate, lung, and NF2 trialsJul 17Weekly roundup, 6 itemsAstraZenecaosimertinib